Welcome to HUMIGEN, The Institute for Genetic Immunology.
HUMIGEN is the immunology and inflammation genetics arm of Genesis Biotechnology Group (GBG). Our mission is to understand the relationship between human health, the immune system, and disease pathogenesis and outcome.
HUMIGEN was formed in 2007 with a role to develop a program of translational research into being that would address the role of inflammation in pathogenesis, and understand its genetics. Using this information, we probe disease biology in order to identify targets for therapeutic intervention. Our ultimate goal is to contribute to the diagnosis and treatment of immune system-mediated diseases, and advance human health.
New Article on News-Medical.net
Type 3 interferons and T helper 2 cells: an interview with Grant Gallagher, Managing Director, HUMIGEN